Modafinil is an inhibitor, a smart drug, and medicine that improves wakefulness for those suffering from narcolepsy. It's a fast-acting nootropic that enhances cognitive performance. But, you may not know exactly how it works.
We'll break down the science behind this so-called "smart pill" to explain how it enhances cognition.
What is Modafinil?
Modafinil is a wakefulness-promoting agent which helps to enhance focus and productivity. It is used as a central nervous system stimulant to improve cognitive functions and belongs to a class of prescription medicines.
Mechanism of Actions
Modafinil is associated with caffeine in increasing the level of adenosine in the brain, reducing the activity of sleep-promoting neurons to prevent daytime sleepiness.
It has two distinct phases of action. The first phase occurs when the drug agent enters the brain and causes a rapid increase in dopamine concentration and direct inhibition of dopamine reuptake.
This neurotransmitter plays a significant role in arousal, motivation, attention, reward, and pleasure.
When you take medicine, your brain releases more neurotransmitters, making you feel more awake and focused. You also have better memory and problem-solving skills.
The second phase is where the drug increases the number of neurotransmitters in the brain. This is how medicine works. It affects the receptors and improves the level of dopamine in the brain by binding to the receptors.
The second phase of action is crucial for Modafinil. It has a longer duration of action than the first phase. The second phase lasts for about 8 hours.
Treatment of Patients with Traumatic Brain Injury
To help minimize the cost and the length of stay for patients with traumatic brain injury (TBI), the National Institutes of Health (NIH) is currently funding Modafinil's clinical trial.
According to a review, the primary goal of the research is to determine if Modafinil, an FDA-approved medication for narcolepsy, daytime drowsiness, and obstructive sleep apnea, can be used as a safe and effective treatment for post-traumatic brain injury in humans.
Stimulant Effects and Wake-Promoting Substances
Modafinil is an inhibitor with antioxidative and neuroprotective effects unrelated to its stimulant properties.
The neurocognitive processes responsible for the drug's cognitive-enhancing efficacy and potential in the treatment of amphetamine addiction are proposed.
The neuroprotection of Modafinil protects the brain from damage caused by free radicals.
Free radicals may be involved in narcolepsy and cellular damage, suggesting a common target of action for its ability to oppose both of these effects.
Medication Development for Amphetamine Dependence
The medication has been studied to improve cognitive function in people with amphetamine dependence.
Amphetamine dependence is a severe medical condition that can be managed with medication. There are several types of amphetamine addiction, each requiring a different kind of treatment.
Drug therapy for amphetamine dependence typically includes medications to lessen cravings, enhance self-care behaviors, and prevent relapse.
The pharmacological efficacy of Modafinil is similar to amphetamine, but it has a longer half-life and is a more potent stimulant and inhibitor.
Pharmacodynamics refers to how a drug affects the body, while pharmacokinetics refers to how it is absorbed and metabolized by the body.
Pharmacodynamics starts when the drug is absorbed into the bloodstream and reaches the brain.
Modafinil affects the parts of the brain that control the arousal level. This is why it is called a wakefulness drug. It increases the production of serotonin in the brain, including direct inhibition of dopamine reuptake. It also adds the amount of glutamate.
Modafinil is a stimulant that helps boost the production of dopamine, norepinephrine, and serotonin in the brain.
Modafinil's pharmacokinetics were linear and dose-dependent. Orally administered Modafinil was extensively biotransformed in the liver to the inactive metabolites acid and sulphone before being eliminated primarily in the urine (elimination half-life 9 to 14 hours).
The pharmacokinetics of Modafinil is not modified by volunteer age or food intake in a clinically meaningful way. However, hepatic or renal impairment individuals had a more extended maximum plasma concentration and elimination half-life.
The unaltered drug's excretion in the urine varies from 0% to 18.7%, depending on various circumstances.
Modafinil Uses: How Does Modafinil Work?
The FDA approves Modafinil to treat excessive drowsiness associated with narcolepsy.
Its pharmacology and clinical efficacy have been shown to boost wakefulness in volunteer patients with narcolepsy.
In addition, it does not appear to produce any significant effects on mood or psychomotor function.
Preclinical Studies of Modafinil Pill
Modafinil was initially introduced as a wake-promoting agent in 1988 and was first approved by the US Food and Drug Administration in the same year.
It has been viewed throughout its history as a "novel" wake-promoting therapeutic pill, presumably due to its unique pharmacological properties.
Modafinil is an inhibitor with stimulant properties and is likely to improve brain function.
However, there is limited evidence that it has cognitive-enhancing effects in high-performing well-rested volunteer individuals.
The metabolic drug may improve a patient's neurocognitive performance in average but not high IQ subjects.
Placebo-controlled studies are used to evaluate the effects of medication without the use of an active drug.
In this kind of human study, the volunteer patient participants are given either a real or fake treatment, and their health is monitored over time.
The research evaluation can determine whether a particular medicine is effective and safe.
These studies can also help researchers identify potential side effects of medicines on the volunteers.
Modafinil Effects & Benefits
Reviews have shown Modafinil's advantages over amphetamines and methylphenidate in patients with narcolepsy because of its lack of rebound phenomena after treatment withdrawal and low abuse potential.
A recent human study at the University of Rochester Medical Center found that Modafinil is an effective cure for cocaine dependence. The research suggests that it may help patients with this disorder avoid relapse.
It is generally well-tolerated and has a tolerability profile similar to that of a placebo, taken once a day by patients and orally administered for therapeutic benefits.
Effects on Sleep
As a prescription-only medication, it's been proven to promote sleep since the 1980s. There is some evidence that it can effectively treat other conditions such as daytime sleepiness, obstructive sleep apnea, and idiopathic hypersomnia.
It is also used as a pick-me-up for people who experience problems with concentration and memory and for people who have chronic fatigue syndrome.
Modafinil is a metabolic drug known to improve the levels of neurotransmitters in the brain.
The effects on neurotransmitters may be due, in part, to an indirect process or an upstream site of action.
Studies and reviews show that it does not affect GABA in the thalamus or hippocampus. Still, GABA levels were decreased in most brain regions studied: the cortex, medial preoptic area of the hypothalamus, posterior hypothalamus, nucleus accumbens, pallidum, and striatum.
Modafinil reduces striatal GABA, increases levels of reduced glutathione in MPTP damaged neurons, and reduces levels of the lipid peroxidation product malondialdehyde.
It has been shown to have neuroprotective effects by inhibiting CYP2C19 and is a potent suppressor in hepatocytes of CYP2C9.
It also does not show fos-immunoreactivity in the basal forebrain.
Administration of Modafinil Tablet
The recommended dose for narcolepsy is 200 mg orally administered once daily in the morning.
For shift work disorder, the dose is taken about one hour before the work shift.
Based on reviews, the pediatric use of the supplement has not been established, while severe skin rashes have been reported with its use in children.
Elderly patients might use lower doses, while pregnant women should carefully consider using it during pregnancy.
The most common adverse effects are headache, nausea, and decreased appetite.
Other commonly reported adverse effects (5% to 10%) include anxiety, insomnia, dizziness, diarrhea, and rhinitis.
Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and DRESS have been reported in postmarketing surveillance with its use. These life-threatening rashes appear extremely rare.
Its pharmacology shows that clinical manifestations of overdose are relatively mild but may include hypertension, tachycardia, agitation, and psychosis.
About 20 percent of overdose cases require medical treatment. Symptoms typically respond to supportive therapy, although augmentation with benzodiazepines is occasionally needed.
The extreme result of toxicity shows intrauterine growth restriction and spontaneous abortion with its use.
In studies conducted in rats (Modafinil, Armodafinil) and rabbits (Modafinil), developmental toxicity was observed at clinically relevant plasma exposures.
Addiction and Dependence
Modafinil's pharmacology appears to have a very low risk of addiction and dependence. It has similar biological pathways to addictive central nervous system stimulants and enzymes, and some studies have found it to have mood-elevating qualities, but to a lesser extent.
It is a non-amphetamine stimulant acting by a synergistic combination of processes, including direct dopamine reuptake inhibition.
Modafinil, or Provigil, is a wakefulness-promoting medication that helps people stay awake during the day. It's used to treat narcolepsy and shift work sleep disorder, but it can also boost energy in people running on low batteries.
It's unclear whether these effects are different from those produced by caffeine. Modafinil does not cause euphoria or deviations (abuse) from the patient's prescribed dosages.
The FDA has classified the drug as a Schedule IV restricted substance with good medicinal uses and a low potential for addiction.
According to the International Narcotics Control Board, it is neither a narcotic nor a psychotropic substance.
Modafinil is not for everyone and should only be taken if a physician has prescribed it.
There are no long-term studies on the effects on the brain, so care must be taken when prescribing it to patients.
People who have a known hypersensitivity to Modafinil or its family should have limited consumption or should not take it. It is not recommended for usage in children under 18 due to an increased risk of rare but significant dermatological toxicity.
Modafinil Indications and Interactions
Modafinil may have interactions with other medications. So, if you are currently using other supplements, check with your doctor for the safe management of your medications.
Modafinil may harm hormonal contraceptives for up to a month after discontinuation if it is not well managed.
Its profile may also impair the bioavailability of hydrocortisone by increasing the activity of the CYP3A4 enzyme involved in cortisol elimination.
As a result, in people using CYP3A4-metabolism-inducing enzyme medications like Modafinil, the steroid substitution dose may need to be adjusted. Modafinil is a CYP3A4 enzyme inducer with a modest to moderate effect.
Modafinil Mechanism Of Action: Conclusion
Modafinil has a wide range of effects on the brain and body, including increasing alertness, enhancing cognitive performance, and improving sleep quality. Its primary mechanism of action is the modulation of glutamate receptors.
However, many other processes are yet fully understood for their effective management. Modafinil is a popular drug used by students to help them stay awake during exams and by athletes to help them perform better.